102 related articles for article (PubMed ID: 3444167)
1. [A study of urological tumor-associated antigens. IV. Immunocytochemical study of TPA, ABH antigen using urothelial exfoliated cells in bladder tumors].
Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1746-53. PubMed ID: 3444167
[No Abstract] [Full Text] [Related]
2. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
Proca E; Lucan M; Pîslăraşu M
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
[No Abstract] [Full Text] [Related]
3. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
Vogel J; Oehr P; Maisey R; Adolphs HD
Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597
[TBL] [Abstract][Full Text] [Related]
4. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
Kobayashi H
Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
[TBL] [Abstract][Full Text] [Related]
5. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
Hammou JC; Fella C; Vacant J
Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
[No Abstract] [Full Text] [Related]
6. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
[TBL] [Abstract][Full Text] [Related]
7. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L
Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
[TBL] [Abstract][Full Text] [Related]
8. [Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma].
Tizzani A; Casetta G; Cavallini A; Piana P; Piantino P
Minerva Urol Nefrol; 1990; 42(2):69-71. PubMed ID: 2392743
[TBL] [Abstract][Full Text] [Related]
9. Phenotypically heterogeneous deletion of the ABH antigen from the transformed bladder urothelium. A scanning electron microscope study.
De Harven E; He S; Hanna W; Bootsma G; Connolly JG
J Submicrosc Cytol; 1987 Oct; 19(4):639-49. PubMed ID: 3430650
[TBL] [Abstract][Full Text] [Related]
10. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
Srougi M; Alves VA; Gayotto LC; Arap S
Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
[No Abstract] [Full Text] [Related]
11. Random biopsies in bladder tumors: in most cases, you shall not!
Zlotta AR
Eur Urol; 2006 Aug; 50(2):186-93. PubMed ID: 16814925
[No Abstract] [Full Text] [Related]
12. [A study of urological tumor associated antigens. III. Immunohistochemical study of tissue polypeptide antigen (TPA) in bladder tumors].
Tsujihashi H; Uejima S; Park YC; Akiyama T; Kurita T; Iguchi M
Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):35-43. PubMed ID: 3398377
[No Abstract] [Full Text] [Related]
13. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
Weinstein RS; Miller AW; Coon JS
Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
[No Abstract] [Full Text] [Related]
14. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
15. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
[No Abstract] [Full Text] [Related]
16. Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up study.
Senatore S; Zizzi L; Blasi C; Alfieri G; Saccani Jotti G; Gabrielli M; Luccarelli S
Oncology; 1990; 47(1):37-42. PubMed ID: 2300382
[TBL] [Abstract][Full Text] [Related]
17. Scanning electron microscopy of immuno-gold labeled antigens associated with bladder cancer.
de Harven E; Connolly JG; Wang Y; Hanna W; Bootsma G
Scanning Microsc; 1990 Jun; 4(2):467-76; discussion 476-7. PubMed ID: 2402614
[TBL] [Abstract][Full Text] [Related]
18. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients].
Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110
[TBL] [Abstract][Full Text] [Related]
19. [CEA and TPA in bladder carcinoma].
Latella G; Ciarniello P; Fusco A; Liberti M; Gentile V; De Berardinis E; Von Heland M
Minerva Med; 1986 Mar; 77(13):505-6. PubMed ID: 3703342
[No Abstract] [Full Text] [Related]
20. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].
Kaneko K; Suzuki T; Takasaki E
Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
